VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
1-Year Est. Return
26.22%
1 Year Est. Return
-26.22%
AUM
$82.1M
AUM Growth
+$21.9M
(+36%)
Holding
8
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monte Rosa Therapeutics
GLUE
$794M
| $25.5M | 31.04% |
5,652,922
|
|
||
2
CRISPR Therapeutics
CRSP
$5.82B
| $24.2M | 29.52% |
498,558
|
|
||
|
JBIO
3
Jade Biosciences
JBIO
$451M
| $15.2M | 18.56% |
+1,525,820
|
|
||
4
Skye Bioscience
SKYE
$48M
| $8.39M | 10.22% |
2,007,704
|
|
||
5
Repare Therapeutics
RPTX
$79M
| $3.68M | 4.48% |
2,646,657
|
|
||
|
CTNM
6
Contineum Therapeutics
CTNM
$321M
| $2.15M | 2.62% |
542,628
-375,535
|
|
||
7
Tempest Therapeutics
TPST
$45.2M
| $1.83M | 2.23% |
269,772
-1
|
|
||
8
Adverum Biotechnologies
ADVM
$94.6M
| $1.09M | 1.33% |
506,821
|
|